BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm, announce the successful acquisition of BioDuro’s drug product development and manufacturing operations in Irvine, California, resulting in the formation of Forma Life Sciences, Inc. (FORMA), a Delaware corporation established to hold and operate the acquired assets. The transaction includes two highly accredited facilities supporting U.S.-based development and manufacturing of high-quality pharmaceutical drug products. Now operating under the FORMA name, the Irvine Fairbanks facility comprises approximately 65,000 sq. ft. and has produced high-value pharmaceutical drug products for more than 20 years.
Read the full article: BioSelective Capital Investments Completes Acquisition of BioDuro’s Irvine, California Drug Product Development and Manufacturing Operations //
Source: https://www.businesswire.com/news/home/20260120433880/en/BioSelective-Capital-Investments-Completes-Acquisition-of-BioDuros-Irvine-California-Drug-Product-Development-and-Manufacturing-Operations